| VIEWPOINT |
|
| Year : 2018 | Volume
: 2
| Issue : 2 | Page : 152-157 |
|
|
Depot preparation in schizophrenia: Indian outlook
Mohit Shah1, Disha Parikh2, Sagar Karia2
1 Consultant Psychiatrist, Unlimited Potentialities, Mumbai, Maharashtra, India
2 Department of Psychiatry, LTMMC and GH, Mumbai, Maharashtra, India
Correspondence Address:
Mohit Shah
603, Aura Biplex Senate, Above Kalyan Jewellers, Borivali West, Mumbai, Maharashtra
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/aip.aip_41_18
|
|
|
Schizophrenia is a mostly chronic mental disorder, and symptomatic relapse is frequently observed. It is often associated with social and/or occupational decline that can be difficult to reverse. Most patients with the illness need long-term pharmacological treatment and antipsychotic drugs represent the mainstay of clinical care. Long-acting injectable antipsychotics are an important alternative to oral medication, particularly advantageous in the context of compliance management.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
